Seres Therapeutics, Inc. - Special Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Seres SER-109 Investor Event Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Eric Shaff, CEO. Thank you. Please go ahead, sir.
Good morning, and welcome to Seres Therapeutics SER-109 Investor Day. Thank you for spending time with us this morning. This is an important moment for Seres and for the microbiome space in general. We believe that our upcoming SER-109 Phase III readout will be the catalyst to demonstrate that the microbiome has moved from an emerging treatment modality to one that is here now. Our primary goal for today is to provide you with information that will enable you to better understand and appreciate our pending SER-109 Phase III results, which we are expecting this summer.
Now we will be making forward-looking statements in today's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |